COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,160 Articles (22,703 medRxiv, 8,457 bioRxiv)

Most recent first Previous |  Page 968: Articles 9671-9680  | Next

Forecasted trends of the new COVID-19 epidemic due to the Omicron variant in Thailand, 2022
Suphanchaimat, R., Teekasap, P., Nittayasoot, N., Phaiyarom, M., Cetthakrikul, N.
10.1101/2022.01.24.477479 — Posted: 2022-01-24
SARS-CoV-2 viremia precedes an IL6 response in severe COVID-19 patients: results of a longitudinal prospective cohort
Roy-Vallejo, E., Cardenoso, L., Triguero-Martinez, A., Chicot Llano, M., Zurita Cruz, N. D., Avalos Perez-Urria, E., Barrios, A., Hernando Santos, J., Ortiz, J., Rodriguez-Garcia, S. C., Ciudad Sanudo, M., Marcos, C., Garcia Castillo, E., Fontan Garcia-Rodrigo, L., Gonzalez, B., Mendez, R., Iturrate, I., Sanz-Garcia, A., Villa, A., Sanchez Azofra, A., Quicios, B., Arribas, D., Alvarez-Rodriguez, J., Patino, P., Trigueros, M., Uriarte, M., Martin Ramirez, A., Arevalo, C., Galvan-Roman, J. M., Garcia-Vicuna, R., Ancochea, J., Munoz-Calleja, C., Fernandez-Ruiz, E., de la Camara, R., Suarez Fernan
10.1101/2022.01.24.22269734 — Posted: 2022-01-24
Evidence on the role of journal editors in the COVID19 infodemic: metascientific study analyzing COVID19 publication rates and patterns
Grisi, G., Barreto Segundo, J. d. D., Freire, C. V., Matias, D., Cruz, M., Laporte, L. R., Medina, D., Taniguchi, T. M., Requiao, L., Goes, B., Correia, L. C. L.
10.1101/2022.01.23.22269716 — Posted: 2022-01-24
Estimated Fraction of Incidental COVID Hospitalizations in a Cohort of 250 High-Volume Hospitals Located in 164 Counties
Harris, J. E.
10.1101/2022.01.22.22269700 — Posted: 2022-01-24
Are allergic diseases a risk factor for systemic side effects after COVID-19 vaccines?
ATAYIK, E., Aytekin, G.
10.1101/2022.01.23.22269704 — Posted: 2022-01-24
Early Alveolar Epithelial Cell Necrosis is a Potential Driver of ARDS with COVID-19
Tojo, K., Natsuhiro, Y., Tamada, N., Mihara, T., Abe, M., Goto, T.
10.1101/2022.01.23.22269723 — Posted: 2022-01-24
Detection of SARS-CoV-2 in Different Human Biofluids Using the Loop-Mediated Isothermal Amplification Assay: A Prospective Diagnostic Study in Fortaleza, Brazil
Clementino, M., Cavalcante, K. F., Viana, V. A. F., Silva, D. D. O., Damasceno, C. R., de Souza, J. F., Gondim, R. N. D. G., Jorge, D. M. d. M., Magalhaes, L. M. V. C., Arruda, E., Neto, R. d. J. P., Medeiros, M. S., dos Santos, A. A., Magalhaes, P. J. C., Mello, L. P., Neto, E., Lima, A. A., Havt, A.
10.1101/2022.01.23.22269711 — Posted: 2022-01-24
A NOVEL METHOD FOR HANDLING PRE-EXISTING CONDITIONS IN PREDICTION MODELS FOR COVID-19 DEATH
Murata, G. H., Murata, A. E., Campbell, H. M., Mao, J. T.
10.1101/2022.01.22.22269694 — Posted: 2022-01-24
Systemic adverse effects induced by the BNT162b2 vaccine are associated with higher antibody titers from 3 to 6 months after vaccination
Koike, R., Sawahata, M., Nakamura, Y., Nomura, Y., Katsube, O., Hagiwara, K., Niho, S., Masuda, N., Tanaka, T., Sugiyama, K.
10.1101/2022.01.23.22269706 — Posted: 2022-01-24
Should healthcare workers with SARS-CoV-2 household exposures work? A Cohort Study.
Quach, C., Blanchard, A. C., Lamarche, J., Audy, N., Lamarre, V.
10.1101/2022.01.23.22269719 — Posted: 2022-01-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).